Suchergebnisse - "Ryan, Robert J"

PubPharm (4)

1

Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML

enthalten in: Journal of hematology & oncology | 2021

von Cortes, J. | Lin, T. | Uy, G. | +3

2

Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351 : phase 3 post hoc analyses

enthalten in: Blood advances | 2021

von Lin, T. | Rizzieri, D. | Ryan, D. | +10

3

Analysis of Time to Complete Response after Defibrotide Initiation in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation

enthalten in: Transplantation and cellular therapy | 2021

von Richardson, P. | Smith, A. | Kernan, N. | +3

CommentIn: Transplant Cell Ther. 2021 Feb;27(2):192-193. - PMID 33781546

4

Healthcare resource utilization in a phase 3 study of CPX-351 in patients with newly diagnosed high-risk/secondary acute myeloid leukemia

enthalten in: Journal of medical economics | 2020

von Villa, K. | Ryan, R. | Chiarella, M. | +1

1
[1]